These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 11689778)

  • 1. Late hepatic allograft dysfunction.
    Wiesner RH; Menon KV
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S60-73. PubMed ID: 11689778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver biopsy interpretation for causes of late liver allograft dysfunction.
    ; Demetris AJ; Adeyi O; Bellamy CO; Clouston A; Charlotte F; Czaja A; Daskal I; El-Monayeri MS; Fontes P; Fung J; Gridelli B; Guido M; Haga H; Hart J; Honsova E; Hubscher S; Itoh T; Jhala N; Jungmann P; Khettry U; Lassman C; Ligato S; Lunz JG; Marcos A; Minervini MI; Mölne J; Nalesnik M; Nasser I; Neil D; Ochoa E; Pappo O; Randhawa P; Reinholt FP; Ruiz P; Sebagh M; Spada M; Sonzogni A; Tsamandas AC; Wernerson A; Wu T; Yilmaz F
    Hepatology; 2006 Aug; 44(2):489-501. PubMed ID: 16871565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation.
    Duclos-Vallee JC; Sebagh M
    Liver Transpl; 2009 Nov; 15 Suppl 2():S25-34. PubMed ID: 19876939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplantation pathology.
    Hübscher SG
    Semin Liver Dis; 2009 Feb; 29(1):74-90. PubMed ID: 19235661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation.
    Faust TW
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S99-108. PubMed ID: 11689782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late acute rejection after liver transplantation impacts patient survival.
    Uemura T; Ikegami T; Sanchez EQ; Jennings LW; Narasimhan G; McKenna GJ; Randall HB; Chinnakotla S; Levy MF; Goldstein RM; Klintmalm GB
    Clin Transplant; 2008; 22(3):316-23. PubMed ID: 18190550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver disease recurrence after liver transplantation].
    Rakela B J
    Rev Med Chil; 2010 Apr; 138(4):504-10. PubMed ID: 20668801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic liver allograft dysfunction.
    Desai M; Neuberger J
    Transplant Proc; 2009 Mar; 41(2):773-6. PubMed ID: 19328977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent disease after liver transplantation.
    Davern TJ; Lake JR
    Semin Gastrointest Dis; 1998 Jul; 9(3):86-109. PubMed ID: 9700841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cirrhosis after orthotopic liver transplantation in the absence of primary disease recurrence.
    Seyam M; Neuberger JM; Gunson BK; Hübscher SG
    Liver Transpl; 2007 Jul; 13(7):966-74. PubMed ID: 17370332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis.
    Neuberger J
    Liver Transpl Surg; 1995 Sep; 1(5 Suppl 1):109-15. PubMed ID: 9346607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.
    Pappo O; Ramos H; Starzl TE; Fung JJ; Demetris AJ
    Am J Surg Pathol; 1995 Feb; 19(2):192-206. PubMed ID: 7832279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver allograft pathology and biopsy interpretation.
    Portmann B
    Verh Dtsch Ges Pathol; 2004; 88():29-38. PubMed ID: 16892531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology of hepatic transplantation: A review of 62 adult allograft recipients immunosuppressed with a cyclosporine/steroid regimen.
    Demetris AJ; Lasky S; Van Thiel DH; Starzl TE; Dekker A
    Am J Pathol; 1985 Jan; 118(1):151-61. PubMed ID: 3881037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers.
    Krasinskas AM; Demetris AJ; Poterucha JJ; Abraham SC
    Liver Transpl; 2008 May; 14(5):625-32. PubMed ID: 18433038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
    Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
    Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.
    Demetris AJ; Jaffe R; Sheahan DG; Burnham J; Spero J; Iwatsuki S; Van Theil DH; Starzl TE
    Am J Pathol; 1986 Oct; 125(1):161-72. PubMed ID: 3535528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What does the long-term liver allograft look like for the pediatric recipient?
    Hübscher S
    Liver Transpl; 2009 Nov; 15 Suppl 2():S19-24. PubMed ID: 19877293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of diseases following orthotopic liver transplantation.
    Kotlyar DS; Campbell MS; Reddy KR
    Am J Gastroenterol; 2006 Jun; 101(6):1370-8. PubMed ID: 16771963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.